Followers | 49 |
Posts | 18364 |
Boards Moderated | 0 |
Alias Born | 02/26/2001 |
Tuesday, March 06, 2018 6:16:31 PM
Loading...
Loading...
):
* TETRAPHASE PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS, HIGHLIGHTS ACHIEVEMENTS AND KEY 2018 MILESTONES
* Q4 LOSS PER SHARE $0.46
* Q4 REVENUE $2.5 MILLION VERSUS $1.1 MILLION
* Q4 REVENUE VIEW $2.4 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
Next 1/4 we'll see that $7 MILLION reported, earning will be 4x that amount. Not sure how they have to report that.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM